Medicinal Cannabis and Consumer Vulnerability in Australia: A Nexus of Policy and Market Factors

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Gething, Katrina
Erku, Daniel
Scuffham, Paul
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2025
Size
File type(s)
Location
Abstract

Introduction: Following the 2016 legalization of medicinal cannabis (MC) in Australia, significant barriers have led patients to seek unregulated cannabis for therapeutic use. This study examines consumer (patient, carer and family) submissions to a senate inquiry on these barriers to understand how future policy might better reflect patient needs and facilitate access to regulated MC. Methods: Sixty submissions from patients (n = 44), their caregivers or family members (n = 16) were coded using NVivo 12 software and thematically analysed. The findings were presented narratively using a consumer vulnerability framework. Results: The analysis identified three primary barriers to accessing regulated MC: (1) Health practitioners' reluctance to prescribe MC, hindering prescription access, (2) High costs associated with MC and its access process, disproportionately affecting low-income consumers and (3) Dependence on imported MC products, leading to shortages and necessitating product substitutions that incur additional costs and bureaucratic hurdles. Despite these barriers, consumers demonstrated resilience by educating themselves about MC, planning for prescription needs and forming support networks. Patients also turned to illicit MC markets. Conclusion: The study reveals significant barriers to regulated MC access in Australia, highlighting the complex challenges consumers face. The reliance on unregulated sources of MC not only poses legal and health risks but also underscores the urgent need for policy reforms. By addressing the identified barriers, such as alleviating the costs associated with MC and improving approval processes and ensuring product availability, policymakers can better meet consumer needs and facilitate safer access to regulated MC. Patient or Public Contribution: The materials of this document analysis were patient and public submissions to a government enquiry into barriers to a health technology. By providing submissions, both patients and the public were actively engaging in the development of health policy.

Journal Title

Health Expectations

Conference Title
Book Title
Edition
Volume

28

Issue

1

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2025 The Author(s). Health Expectations published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Item Access Status
Note
Access the data
Related item(s)
Subject
Persistent link to this record
Citation

Gething, K; Erku, D; Scuffham, P, Medicinal Cannabis and Consumer Vulnerability in Australia: A Nexus of Policy and Market Factors, Health Expectations, 2025, 28 (1), pp. e70176

Collections